Shopping Cart
- Remove All
- Your shopping cart is currently empty
TAM-16 is a potent, orally active inhibitor of polyketide synthase 13 (Pks13) with an IC50 value of 0.32 μM, demonstrating promising activity against Mycobacterium tuberculosis. Additionally, TAM-16 inhibits the hERG cardiac ion channel [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | TAM-16 is a potent, orally active inhibitor of polyketide synthase 13 (Pks13) with an IC50 value of 0.32 μM, demonstrating promising activity against Mycobacterium tuberculosis. Additionally, TAM-16 inhibits the hERG cardiac ion channel [1] [2]. |
In vitro | TAM-16 (compound 1) inhibits the M. tuberculosis strain H37Rv with an IC50 value of 0.08 μM [1]. Additionally, TAM-16 (0-10 μM) targets Pks13 to suppress Mycobacterium tuberculosis [1]. |
In vivo | In a study involving a BALB/c mouse model of tuberculosis (TB), oral administration of TAM-16 (compound 1) at a dose of 200 mg/kg daily over a period of 14 days significantly reduced the lung CFU (colony-forming units) count by approximately 0.9 log 10 [2]. This reduction was observed when compared to untreated control mice, indicating that TAM-16 effectively prevents typical pulmonary lesions in a mouse model of TB infection. |
Molecular Weight | 380.44 |
Formula | C22H24N2O4 |
Cas No. | 2030241-59-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.